Adverse Events in Acute Limb Ischemic Patient Undergoing Revascularization

NCT05362266 | Unknown

• 1 other identifier: 052/2565
• Study Type: observational
• Target: 240
• Locations: 1 country
• Sites: 2

Brief Summary

Acute limb ischemia is one of the devastating vascular emergencies that lead to life and limb loss if the appropriate treatment is not reached.The revascularization is a cornerstone in treating acute limb ischemia. The conventional surgical approach includes surgical embolectomy and surgical bypass.From the anesthetic aspect, this emergency condition limits the lengthening cardiovascular assessment of this high-risk patient group which might lead to the uncertainty outcome.With the variety of patients and procedures, we sought to find out the perioperative adverse events, especially major adverse cardiac events, in acute ischemic limb patients undergoing revascularization, in order to increase awareness of the team and properly admit to ICU in a retrospective manner.

Conditions

Major Adverse Cardiac Events; Adverse Effect of Unspecified General Anesthetic

Outcome Measures

Primary Outcomes (1)

• Incidence of major adverse cardiac events

  Incidence of major adverse cardiac events, which are cardiovascular death, myocardial infarction, stroke

  during hospital stay, up to 4 weeks

Secondary Outcomes (2)

• Incidence of the perioperative complication

  during hospital stay, up to 4 weeks

• Factors contribute to the adverse outcome

  during hospital stay, up to 4 weeks

Eligibility Criteria

• Age: 18 Years - 90 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Age more than 18, with acute limb ischemia undergoing revascularization procedure

You may qualify if:

• age more than 18 years
• undergoing revascularization surgery or procedure (surgical revascularization, endovascular revascularization, hybrid revascularization, catheter directed thrombolysis)

You may not qualify if:

• incomplete data during perioperative period

Sponsors & Collaborators

• Mahidol University: lead

Study Sites (2)

Anesthesiology department, Siriraj Hospital, Mahidol University

Bangkok, Thailand

RECRUITING

MahidolU

Bangkok, Thailand

RECRUITING

MeSH Terms

Conditions

Cardiovascular Diseases

Central Study Contacts

Tachawan Jirativanont, MD

CONTACT

+66816422817; tachawan.jir@mahidol.acth

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: RETROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: April 11, 2022
• First Posted: May 5, 2022
• Study Start: April 10, 2022
• Primary Completion: March 1, 2023
• Study Completion: April 1, 2023
• Last Updated: May 5, 2022

Record last verified: 2022-05

Data Sharing

• IPD Sharing: Will not share

Locations

TH (2)